INTEGRATED BIOPHARMA INC Retained Earnings
INTEGRATED BIOPHARMA INC (INBP) had Retained Earnings of -$32.90 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-08
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$32.90M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$32.06M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$31.30M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$31.42M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$32.90M 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$32.06M 10-Q · filed 2026-02-11 |
| 2025-09-30 | -$31.30M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$31.42M 10-Q · filed 2026-05-08 |
| 2025-03-31 | -$31.24M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$31.85M 10-Q · filed 2025-02-13 |
| 2024-09-30 | -$31.97M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$32.23M 10-K · filed 2025-09-23 |
| 2024-03-31 | -$32.49M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$32.78M 10-Q · filed 2024-02-12 |
| 2023-09-30 | -$32.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$32.34M 10-K · filed 2024-09-20 |
| 2023-03-31 | -$32.38M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$32.40M 10-Q · filed 2023-02-10 |
| 2022-09-30 | -$32.34M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$32.30M 10-K · filed 2023-09-15 |
| 2022-03-31 | -$33.80M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$34.60M 10-Q · filed 2022-02-10 |
| 2021-09-30 | -$35.63M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$36.14M 10-K · filed 2022-09-13 |
| 2021-03-31 | -$40.65M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$41.89M 10-Q · filed 2021-02-12 |
| 2020-09-30 | -$43.12M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$44.16M 10-K · filed 2021-09-02 |
| 2020-03-31 | -$46.06M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$46.99M 10-Q · filed 2020-02-12 |
| 2019-09-30 | -$47.95M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$48.26M 10-K · filed 2020-09-23 |
| 2019-03-31 | -$48.62M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$49.55M 10-Q · filed 2019-02-13 |
| 2018-09-30 | -$49.79M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$49.95M 10-K · filed 2019-08-29 |
| 2018-03-31 | -$50.77M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$51.16M 10-Q · filed 2018-02-09 |
| 2017-09-30 | -$50.81M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$50.63M 10-K · filed 2018-09-12 |
| 2017-03-31 | -$52.17M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$52.41M 10-Q · filed 2017-02-10 |
| 2016-09-30 | -$52.33M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$52.98M 10-K · filed 2017-09-01 |
| 2016-03-31 | -$53.72M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$53.76M 10-Q · filed 2016-02-19 |
| 2015-09-30 | -$53.69M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$53.94M 10-K · filed 2016-09-02 |
| 2015-03-31 | -$53.82M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$53.72M 10-Q · filed 2015-02-17 |
| 2014-09-30 | -$54.27M 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$54.67M 10-K · filed 2015-09-04 |
| 2014-03-31 | -$54.55M 10-Q · filed 2014-05-14 |
| 2013-12-31 | -$54.10M 10-Q/A · filed 2014-02-13 |
| 2013-09-30 | -$54.50M 10-Q · filed 2013-11-14 |
| 2013-06-30 | -$54.80M 10-K · filed 2014-09-08 |
| 2013-03-31 | -$55.58M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$55.05M 10-Q · filed 2013-02-19 |
| 2012-09-30 | -$55.87M 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$54.89M 10-K · filed 2013-09-30 |
| 2012-03-31 | -$53.34M 10-Q · filed 2012-05-21 |
| 2011-12-31 | -$52.60M 10-Q · filed 2012-02-21 |
| 2011-09-30 | -$51.82M 10-Q · filed 2011-11-21 |
| 2011-06-30 | -$52.18M 10-K · filed 2012-10-15 |